Quantcast
Venom Peptides Show Promise In Halting The Growth And Spread

Venom Peptides Show Promise In Halting The Growth And Spread Of Cancer

redOrbit Staff & Wire Reports - Your Universe Online Bee stings and snake bites are not typically viewed as things that are beneficial to a person’s health, but new research out of the University of Illinois suggests that they could be...

Latest Management of cancer Stories

2014-08-15 23:06:41

AccuBoost Announces First Breast Cancer Patient Treatments at the Midwestern Regional Medical Center in Zion, IL Tyngsboro, MA (PRWEB) August 15, 2014 Advanced Radiation Therapy, creators of the AccuBoost Breast Brachytherapy technology, is pleased to announce that it has entered into an agreement with the Midwestern Regional Medical Center of Zion, IL to offer the AccuBoost treatment option to their patients undergoing breast conservation therapy (BCT). Treatments utilizing the AccuBoost...

2014-08-11 08:29:09

Patented Technology Enables Accurate Delivery of a Chemotherapeutic Drug to Targeted Tumor Cells, Reducing Drug-related Toxicity without Sacrificing Therapeutic Impact SYDNEY, Aug. 11, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No....

2014-08-05 08:33:13

Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today publication of a case study in which the company's comprehensive tumor profiling service, Caris Molecular Intelligence(TM), helped guide successful...

2014-07-30 08:31:59

SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the appoint of Gregory T. Lucier as chairman of Epic's board of directors. Mr. Lucier was previously chairman and CEO of Life Technologies (formerly Invitrogen). Mr. Lucier joins Epic's board of directors to provide expertise as Epic commercializes its circulating...

2014-07-28 13:22:50

Cancer Research UK Cancer Research UK scientists at Barts Cancer Institute have found that targeting a molecule in blood vessels can make cancer therapy significantly more effective, according to research published in Nature today (Sunday). The team at Barts Cancer Institute, part of Queen Mary University of London, have found that a molecule, called focal adhesion kinase (FAK), signals the body to repair itself after chemotherapy or radiotherapy, which kill cancer cells by damaging...

2014-07-24 23:05:03

The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. Bethesda, MD (PRWEB) July 24, 2014 The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. This is an...

2014-07-23 08:32:41

Making a Difference Through Scientific Research and Discovery BOSTON, July 23, 2014 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer's Medical Advisory Board Member Adam Bass, MD, serves as co-Chair of The Cancer Genome Atlas (TCGA) Gastric Cancer Project, Director for Translational Research for the Center for Esophageal and Gastric Cancer at the Dana-Farber Cancer Institute, and is an associate member of the Broad Institute of MIT and Harvard. The TCGA Gastric...

2014-07-18 16:23:07

MRI-Guided Radiation Therapy Selected as Hot Topic for Largest Annual Gathering of Medical Physicists CLEVELAND, July 18, 2014 /PRNewswire/ -- ViewRay(TM) Incorporated, a privately held medical device company, will be featuring its MRIdian(TM) (me-rid-i-an) system in booth 639 at the 2014 annual meeting of the American Association of Physicists in Medicine (AAPM), which will be held July 20-24 in Austin, TX. The MRIdian system - the world's first and only MRI-guided radiation...

2014-07-16 23:10:21

For the first time ever, Prostate cancer patients can complete a survey describing how their diagnosis changed their lives. New York, NY (PRWEB) July 16, 2014 Prostate cancer disrupts men's lives in ways that are unimaginable. Now, for the first time ever, a national survey is asking men to describe their experiences regarding life after Prostate Cancer diagnosis. The National Men's Cancer Survivor support and advocacy nonprofit, Malecare Cancer Support, designed and launched...

2014-07-15 12:29:13

This collaboration complements world-class cancer care with sophisticated scientific research focused on providing targeted therapies DANVILLE, Pa. and HAMBURG, Germany, July 15, 2014 /PRNewswire-USNewswire/ -- Indivumed, a leading provider of services enabling individualized cancer therapy, and Geisinger Health System (Geisinger), one of the largest integrated health systems in the United States serving approximately 3 million people, today announced a partnership that will afford...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related